Oncolys BioPharma shares decline despite submission of clinical trial application for OBP-301 in new indication
Shares of Oncolys BioPharma Inc. <4588> traded softly on Thursday. Following Wednesday's market close, Oncolys BioPharma announced that it filed a clinical trial notification with the Pharmaceuticals and Medical Devices Agency (PMDA) for a Phase 1b/2a clinical trial of its oncolytic virus OBP-301 targeting the new indications of lower rectal cancer and anal cancer. The study will evaluate the efficacy and safety of OBP-301 combined with preoperative chemoradiotherapy. Oncolys BioPharma aims to begin dosing during the fiscal year ending December 2026. Although the stock opened higher on the disclosure, buying momentum stalled, and the shares faced profit-taking pressure.
Source: MINKABU PRESS
*Translated by generative AI. Click here for the original article.
Related Articles
-
Tokyo stocks plunge 1,300 points in morning session amid profit-taking and geopolitical concerns
Thu Jun 4, 2026 11:51 am JST Market -
"Drones" ranks 17th as limit on simultaneous flight operations per operator removed
Thu Jun 4, 2026 12:21 pm JST Feature -
Active stocks (morning session) - Mitsubishi Heavy Industries, eSOL, KeePer Tech
Thu Jun 4, 2026 11:32 am JST Catalyst -
Saikaya Department Store tops "rising sell predictions" among individual investors: Minkabu survey
Thu Jun 4, 2026 11:25 am JST Catalyst -
Key headlines from morning session on the 4th
Thu Jun 4, 2026 11:30 am JST Catalyst -
Arclands shares firm after releasing May sales results
Thu Jun 4, 2026 10:42 am JST Catalyst -
SoftBank Group drops over 10% as profit-taking intensifies, TOYOTA MOTOR CORPORATION <7203> reclaims top spot in market capitalization
Thu Jun 4, 2026 11:13 am JST Catalyst -
ISB CORPORATION shares remain firm after Axium Capital increases stake
Thu Jun 4, 2026 10:37 am JST Catalyst -
eSOL shows distinctive uptrend as focus grows on growth capacity in physical AI domain
Thu Jun 4, 2026 10:55 am JST Catalyst -
Hong Kong's Hang Seng Index opens at 25,465.30 on the 4th, down 167.91 points
Thu Jun 4, 2026 10:43 am JST Market